Page 14 - தலைமை மருத்துவ அதிகாரி ப்ரொஃபெஸர் பால் கெல்லி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share on Twitter A small group of people in Australia are among the lucky few who ve now received their first doses of a COVID-19 vaccine. By October, the government has said it hopes to have the entire adult population vaccinated. But concerns have been raised about the efficacy of the vaccine that most people will receive - the AstraZeneca jab - and whether it’s sufficient to achieve herd immunity. Here s why it’s still an important vaccine despite some questions surrounding it. What are the concerns around the AstraZeneca vaccine? Studies have shown it is about 62 per cent effective in preventing COVID-19. The Pfizer vaccine, which is being rolled out to mainly frontline workers and aged care residents, is about 95 per cent effective.

South africaUniversity of south australiaSouth australiaUnited kingdomPaul kellyLinda selveyAdrian estermanAbrar ahmad chughtaiBrendan murphyImmunisation specialist serviceUniversity of queenslandSchool of public healthUniversity of sydney associate professor nicholas woodDepartment of healthAcademy of sciencesChief medical officer professor paul kelly